Form 4 · Filed Jun 8, 2026, 08:15 PM UTC
ACRS/Aclaris Therapeutics, Inc.
Humphries William D. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | M | other | 11,580 | — | — | 45,105 |
| Jun 5, 2026 | M | other | 11,580 | — | — | 0 |
| Jun 4, 2026 | A | other | 42,350 | — | — | 42,350 |
| Jun 4, 2026 | A | other | 10,987 | — | — | 10,987 |
Source: SEC EDGAR raw filing ↗ · Accession 0001674278-26-000002